All Curated Mutation Sites in SARS-CoV-2

Back to Mutation Home

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in SARS-CoV-2 related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Furin cleavage site

Methyltransferase

Non-coding region

Keyword: Cell line-39827186

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	39827186	A264D	NTD	S	Cell line	I	View
2	39827186	483delV	S	S	Cell line	G	View
3	39827186	A484K	RBD	S	Cell line	G I	View
4	39827186	D450N	RBD	S	Cell line	G I	View
5	39827186	F486P	RBD	S	Cell line	G	View
6	39827186	K356T	RBD	S	Cell line	G I	View
7	39827186	N460K	RBD	S	Cell line	G I	View
8	39827186	R493Q	RBD	S	Cell line	G	View
9	39827186	144delY	NTD	S	Cell line	G I	View
10	39827186	F157S	NTD	S	Cell line	G I	View
11	39827186	H245N	NTD	S	Cell line	G I	View
12	39827186	R158G	NTD	S	Cell line	G I	View
13	39827186	V16insMPLF	NTD	S	Cell line	G I	View
14	39827186	E554K			Cell line	G I	View
15	39827186	K403R			Cell line	G	View
16	39827186	N450D			Cell line	G I	View
17	39827186	N481K			Cell line	G	View
18	39827186	P621S			Cell line	G I	View
19	39827186	Q493R			Cell line	G	View
20	39827186	S621P			Cell line	G	View
21	39827186	V445H			Cell line	G	View
22	39827186	P681R			Cell line	G	View
23	39827186	R21T			Cell line	G	View
24	39827186	E484K			Cell line	G	View

Contents
Description

The table shows all curated mutation sites of SARS-CoV-2 in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.